EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Tumour Glyco‐Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment

Aoise O'Neill, Norashikin Zakaria, Hannah Egan, Oliver Treacy, Aisling M Hogan, Michael O'Dwyer, Sean O Hynes, Aideen E Ryan

European Journal of Immunology · 2025-07 · 55 (7)

DOI: 10.1002/eji.70000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 16.07.2025. Verfasst von Aoise O'Neill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Irel…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Stromal Cells, N-Acetylneuraminic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Ireland Starting Investigator Grant, Health Research Board-HRCI Irish Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumour microenvironment (TME) comprises a complex interplay of tumour cells, nonmalignant cells (including endothelial, immune, and stromal cells), and secreted factors within the extracellular matrix (ECM). Immunosuppression within the TME significantly hinders the efficacy of cancer immunotherapies. Stromal‐rich TMEs, characterised by an abundance of mesenchymal stromal cells (MSCs) and cancer‐associated fibroblasts (CAFs), are particularly immunosuppressive and associated with poor responses to conventional and immune‐based therapies. Glycans, carbohydrate structures on cell surfaces, are dynamically regulated during tumourigenesis and mediate crucial cell–cell communications through receptor–ligand interactions. Sialylation, the addition of sialic acids to glycans, forms sialoglycans that can engage inhibitory Siglec receptors expressed on immune cells and promote immunosuppressive signalling. Emerging evidence implicates aberrant sialylation in the TME as a key driver of immunosuppression. More recently, sialylation of stromal cells in the TME has been shown to suppress anti‐tumor immunity. This review explores the role of sialylation within stromal‐rich, immunosuppressive TMEs, focusing on how specific sialic acid/Siglec interactions dictate innate and adaptive immune responses. We discuss the potential of targeting glycoimmune checkpoints to overcome stromal‐mediated resistance and enhance anti‐tumour immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsStromal CellsN-Acetylneuraminic AcidHumansAnimalsImmune TolerancePolysaccharidesCancer-Associated FibroblastsSialic AcidsMesenchymal Stem Cells

Stichwörter der Autor:innen

cancer‐associated fibroblastsimmunosuppressionsialylationstromal cellstumour microenvironment

Substanzen

PolysaccharidesN-Acetylneuraminic AcidSialic Acids

Autor:innen und Institutionen

  • Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
  • Department of Colorectal Surgery, Galway University Hospital, Galway, Ireland.
  • Discipline of Medicine, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Ireland.
  • Division of Anatomical Pathology, Galway University Hospital, Galway, Ireland.

Förderung

  • Research Ireland Starting Investigator Grant
  • Health Research Board-HRCI Irish Cancer Society

Zitieren

APA

O'Neill, A., Zakaria, N., Egan, H., Treacy, O., Hogan, A. M., O'Dwyer, M., Hynes, S. O., & Ryan, A. E. (2025). The Tumour Glyco‐Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment. European Journal of Immunology, 55(7). https://doi.org/10.1002/eji.70000

Vancouver

O'Neill A, Zakaria N, Egan H, Treacy O, Hogan AM, O'Dwyer M, et al. The Tumour Glyco‐Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment. European Journal of Immunology. 2025;55(7). doi:10.1002/eji.70000

BibTeX
@article{ONeill2025,
  author = {O'Neill, Aoise and Zakaria, Norashikin and Egan, Hannah and Treacy, Oliver and Hogan, Aisling M and O'Dwyer, Michael and Hynes, Sean O and Ryan, Aideen E},
  title = {The Tumour Glyco‐Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment},
  journal = {European Journal of Immunology},
  year = {2025},
  volume = {55},
  number = {7},
  doi = {10.1002/eji.70000}
}
Kostenlos starten →